|
Mr. Tarnow was appointed chairman of our Board in February 2003. Since 1995 Mr. Tarnow has been an advisor to and member of the boards of directors of several healthcare-related organizations in the U.S. Canada and Europe including publicly traded companies Axcan Pharma Inc. Thallion Pharmaceuticals Inc. and Xenon Pharmaceuticals Inc. He also serves on the Boards of the University of Illinois College of Law Massachusetts College of Art Foundation and the Food Drug Law Institute. From 1995-2000 he was President and CEO of Boston-based Creative BioMolecules Inc. Prior to that he spent 22 years at Merck & Co. Inc. where he served in a wide variety of positions including heading corporate development President and CEO of Merck Frosst Canada and Executive Vice President of Merck-Medco. | 